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Abstract 
Hydrogels are of significant interest for cell encapsulation and delivery in regenerative medicine. 
Poly(ester amide)s (PEAs) are a class of biodegradable polymers that exhibit promise for 
biomedical applications due to the degradability of the ester and amide linkages in their 
backbones, their preparation from biomolecules such as amino acids, and the ability to readily 
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tune their properties through a modular synthesis approach. Water-soluble PEAs containing 
cationic arginine moieties have previously been developed, but to the best of our knowledge, 
neutral water-soluble PEAs based on non-charged amino acids have not been reported. Using a 
poly(ethylene glycol) (PEG)-based macromonomer, we described here the syntheses of water-
soluble amino acid-containing PEAs containing crosslinkable alkenes in their backbones. These 
PEAs were converted into hydrogels through photoinitiated crosslinking and their properties 
were compared, including gel content, water content, swelling, and Young’s moduli. Subsequent 
cell culture studies on a subset of hydrogels confirmed that human adipose-derived stromal cells 
(ASCs) showed >75% viability at 24 hours post-encapsulation. To explore the potential of the 
hydrogels as cell delivery systems for applications in soft tissue regeneration, adipogenic 
differentiation of the encapsulated ASCs was probed in vitro at 7 days. Analysis of glycerol-3-
phosphate dehydrogenase (GPDH) enzyme activity and intracellular lipid accumulation indicated 
that the hydrogels provided a supportive environment for ASC adipogenesis. Overall, these PEAs 
provide a new platform that warrants further development for regenerative medicine applications.  
Keywords 
Poly(ester amide), hydrogel, regenerative medicine, adipose-derived stromal cell 
 
Introduction 
Hydrogels are commonly used as scaffolds for cell delivery and tissue engineering due to their 
high water content resembling that of soft tissues and high permeability to oxygen, nutrients and 
metabolites [1-3]. Biopolymers such as collagen [4], alginate [5], chitosan [6], hyaluronic acid 
(HA) [7] and chondroitin sulfate [8] have been extensively investigated for the preparation of 
hydrogels. These materials can be degraded enzymatically, and can have favorable biological 
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properties, as they are found naturally within or mimic components of the native extracellular 
matrix (ECM) within human tissues. However, challenges for natural materials include batch-to-
batch reproducibility in their isolation and processing, as well as limitations in the extent to 
which one can tune their chemical and mechanical properties [9].  On the other hand, synthetic 
materials can offer a high degree of chemical and mechanical tunability. Polymers including 
poly(ethylene glycol) (PEG) [10, 11], poly(lactic acid) [11, 12], and poly(N-isopropylacrylamide) 
[13] have been widely explored in hydrogel scaffolds for cell culture and delivery, but without 
functionalization these polymers lack the innate biological cues offered by biopolymers.  
 Poly(ester amide)s (PEAs) are a class of polymers containing ester and amide linkages in 
their backbones, which offer advantages of both polyesters and polyamides, including the 
biodegradability of polyesters and high mechanical strength and thermal stability of polyamides 
[14, 15]. In particular, PEAs derived from amino acids, diols, and dicarboxylic acids have been 
investigated for biomedical applications as they offer advantageous aspects of both natural and 
synthetic polymers. The incorporated amino acids can be recognized by biological systems and 
their enzymatic biodegradation leads to metabolically-degradable building blocks, while their 
properties can be readily tuned by varying their monomer components [16-18]. Most of the 
incorporated amino acids, diols, and dicarboxylic acids are hydrophobic and the backbone esters 
and amides do not impart water-solubility. Consequently, a vast majority of the investigated 
amino-acid containing PEAs have been insoluble in aqueous solution and were processed to form 
particles [19-21], coatings [22-26], or porous scaffolds by electrospinning [27-30] or particulate 
leaching methods [31-33]. However, water-insoluble PEAs cannot be used to prepare hydrogels 
capable of encapsulating cells during the gelation process.  
 Thus far, only a few examples of water-soluble PEAs have been reported. We reported 
PEA-PEG graft copolymers that self-assembled into micelles with PEA cores and PEG coronas 
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for drug delivery applications [34-36]. However, this structural design did not allow for 
crosslinking to form hydrogel networks, as required for cell delivery applications.  Chu and 
coworkers developed cationic water-soluble PEAs based on L-arginine (Arg) [37] and by 
introducing crosslinkable fumaramide moieties into their backbone, they were able to incorporate 
these PEAs into hydrogels with poloxamer-diacrylate [38], methacrylate-functionalized HA [39], 
glycidyl methacrylate chitosan [40], and gelatin [41]. Alternatively, pendent allyl groups could 
also be incorporated as crosslinkers [42]. While cationic Arg moieties are effective in solubilizing 
PEAs in water, and can lead to favorable cell attachment in some cases [38], cationic polymers 
can be toxic at high concentrations [43] and Arg in particular can interact with phospholipids 
through bidentate hydrogen bonding and electrostatics, potentially leading to membrane 
disruption or pore formation [44]. To the best of our knowledge, neutral water-soluble PEAs have 
not yet been reported.  
 Here, we report the development of the first non-charged water-soluble PEAs with 
crosslinkable moieties to enable hydrogel formation and cell encapsulation. Water solubility was 
achieved by the incorporation of a PEG-based macromonomer into the PEA backbone, while 
crosslinking capabilities were introduced using fumaramides. The amino acid and diol 
components were varied. Properties including gel content, water content, swelling, and Young’s 
moduli of the hydrogels fabricated from the different PEAs, and those prepared from the PEAs 
with PEG or chondroitin sulfate crosslinkers were studied. Subsequently in vitro culture studies 
were performed to investigate the potential of the PEA hydrogels as a cell encapsulation 
platform. Human adipose-derived stromal cells (ASCs) were used in these studies, as they 
represent an abundant and readily-accessible pro-regenerative cell source [45]. In particular, the 
delivery of ASCs within hydrogels has shown promise in adipose tissue engineering strategies 
seeking to restore defects caused by trauma, disease or aging [46, 47]. As such, human ASCs 
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were encapsulated into the hydrogels through UV crosslinking and their viability and density 
were assessed at 24 hr post-encapsulation and at 7 days following the induction of adipogenic 
differentiation in culture. In addition, analysis of glycerol-3-phosphate dehydrogenase (GPDH) 
activity, a key enzyme involved in lipid biosynthesis, and intracellular lipid accumulation were 
performed to determine whether the adipogenic differentiation of the encapsulated ASCs was 
impacted by the composition of the PEAs.      
 
Materials and Methods 
General Materials. Monomers 1a (L-phenylalanine-1,4-butanediol diester) [48], 1b (L-
phenylalanine-1,8-octanediol diester) [48], 1c (L-alanine-1,8-octanediol diester) [49] and 3 (di-p-
nitrophenyl fumarate) [48] were synthesized as previously reported. Macromonomer 2 (diamino 
PEG, 2000 g/mol) and PEG-dimethacrylate (PEG-DMA, 2000 g/mol) were synthesized as 
described in the supporting information (Schemes S1-S2). Methacrylated chondroitin sulfate 
(MCS) with 17% methacrylation was prepared as previously reported [50]. PEG diol (2000 
g/mol) was purchased from Alfa Aesar (Haverhill, MA, USA). 4-Dimethylaminopyridine 
(DMAP) and p-toluenesulfonyl chloride were purchased from AK Scientific Inc. (Union City, 
CA, USA). Chondroitin sulfate (50,000 g/mol) was purchased from LKT Laboratories (St. Paul, 
MN, USA). Toluene, NH4OH, MgSO4, Et3N, CH2Cl2, and N,N-dimethylacetamide (DMA) were 
purchased from Caledon Laboratories Inc. (Georgetown, Canada). All other chemicals were 
purchased from Sigma Aldrich (St. Louis, MO, USA). All chemicals were used as received 
unless otherwise noted. Under a nitrogen atmosphere, toluene was distilled over sodium, while 




General procedures. Dialysis was performed using Spectra/Por 6 dialysis tubing from Spectrum 
Laboratories (Rancho Dominguez, CA, USA) with molecular weight cutoff (MWCO) of 10 
kg/mol. 1H nuclear magnetic resonance (NMR) spectra were recorded on either a 400 HMz 
Bruker AvIII HD instrument or a 600 MHz Varian INOVA instrument (Figures S1-S7).  
Chemical shifts (d) are reported in parts per million with the residual protonated solvent signals 
of CDCl3 (d 7.26), D2O (d 4.80) or DMSO-d6 (2.50) as references. Fourier-transform infrared 
(FT-IR) spectra were obtained using a Perkin Elmer FT-IR Spectrum Two instrument in 
attenuated total reflectance (ATR) mode (Figure S8). Size exclusion chromatography (SEC) was 
performed using an instrument equipped with a Waters 515 HPLC pump, a Waters In-Line 
Degasser AF, two PLgel mixed D 5µm (300 x 1.5 mm) columns connected to a corresponding 
PLgel guard column, and a Wyatt Optilab Rex RI detector operating at 658 nm (Figure S9). 
Samples were dissolved in DMF containing 10 mM LiBr and 1% v/v Et3N at a concentration of 
~5 mg/mL. Samples were filtered through 0.22 µm polytetrafluoroethylene (PTFE) syringe 
filters, and then injected using a 50 µL loop. Samples were run at a flow rate of 1 mL/min for 30 
min at 85 °C. The number average molar mass (Mn), weight average molar mass (Mw), and 
dispersity (Đ) were determined relative to poly(methyl methacrylate) (PMMA) standards.  
 
Synthesis of Phe-PEA. Monomer 1a (0.30 g, 0.42 mmol, 0.30 equiv.), macromonomer 2 (2.0 g, 
0.98 mmol, 0.70 equiv.), and monomer 3 (0.50 g, 1.4 mmol, 1.0 equiv.) were dissolved with 
stirring in dry DMA (8.0 mL) at 60 °C. Et3N (0.43 mL, 3.1 mmol, 2.2 equiv.) was added 
dropwise to the solution, and then it was stirred at 70 °C for 6 hr. The resulting solution was 
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The crude 
product was purified by dialysis against DMF (500 mL) for 48 hr. The solution was then 
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concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The product 
was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a white solid. 
Yield: 70%. 1H NMR (400 MHz, DMSO-d6): δ 8.92-8.87 (m, 0.69H), 8.50-8.46 (m, 1.64H), 
7.30-7.19 (m, 4.29H), 6.86-6.83 (m, 2.00H), 4.58-4.52 (m, 0.78H), 3.98 (s, 1.44H), 3.70-3.66 (m, 
1.46H), 3.51 (s, 190H) 3.07-2.89 (m, 2.92H) 1.45 (s, 1.48H). FT-IR: 3510, 3295, 2880, 1740, 
1640, 1550 cm-1. SEC: Mn = 19.9 kg/mol, Mw = 49.2 kg/mol, Đ = 2.46. 
 
Synthesis of Phe-8-PEA. Monomer 1b (0.066 g, 0.084 mmol, 0.30 equiv.), macromonomer 2 
(0.40 g, 0.19 mmol, 0.70 equiv.), and monomer 3 (0.10 g, 0.28 mmol, 1.0 equiv.) were dissolved 
with stirring in dry DMA (2.0 mL) at 60 °C. Et3N (0.10 mL, 0.61 mmol, 2.2 equiv.) was added 
dropwise to the solution, and then it was stirred at 70 °C for 6 hr. The resulting solution was 
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (100 mL). The crude 
product was purified by dialysis against DMF (200 mL) for 48 hr. The solution was then 
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (100 mL). The product 
was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a white solid. 
Yield: 58%. 1H NMR (400 MHz, DMSO-d6): δ 8.89-8.85 (m, 0.69H), 8.50-8.45 (m, 1.58H), 
7.29-7.18 (m, 4.23H), 6.85-6.82 (m, 2.00H), 4.56-4.51 (m, 0.66H), 4.00-3.97 (m, 1.36H), 3.69-
3.67 (m, 1.25H), 3.51 (s, 187H), 3.07-2.89 (m, 2.70H), 1.46 (s, 1.49H), 1.19 (s, 3.61H). FT-IR: 
3520, 3300, 2880, 1730, 1630, 1550 cm-1. SEC: Mn = 20.1 kg/mol, Mw = 56.6 kg/mol, Đ = 2.81. 
 
Synthesis of Ala-PEA. Monomer 1c (0.26 g, 0.42 mmol, 0.30 equiv.), macromonomer 2 (2.0 g, 
0.98 mmol, 0.70 equiv.), and monomer 3 (0.50 g, 1.4 mmol, 1.0 equiv.) were dissolved with 
stirring in dry DMA (8.0 mL) at 60 °C. Et3N (0.43 mL, 3.1 mmol, 2.2 equiv.) was added 
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dropwise to the solution, and then it was stirred at 70 °C for 6 hr. The resulting solution was 
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The crude 
product was purified by dialysis against DMF (500 mL) for 48 hr. The solution was then 
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The product 
was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a white solid. 
Yield: 77%. 1H NMR (400 MHz, DMSO-d6): δ 8.82-8.78 (m, 0.59H), 8.51-8.45 (m, 1.46H), 
6.89-6.83 (m, 2.00H), 4.34-4.29 (m, 0.64H), 4.08-3.97 (m, 1.41H), 3.71-3.65 (m, 1.98H), 3.51 (s, 
177H), 1.54 (s, 1.41H), 1.31-1.22 (m, 5.12H). FT-IR: 3521, 3296, 2880, 1737, 1639, 1546 cm-1. 
SEC: Mn = 18.9 kg/mol, Mw = 56.1 kg/mol, Đ = 2.96. 
 
Fabrication of hydrogels. Pure (Phe-PEA or Ala-PEA alone) and hybrid (Phe-PEA/Ala-PEA + 
PEG-DMA/MCS) hydrogels were fabricated without ASCs for physical characterization studies. 
All hydrogels were made with a polymer solution concentration of 10% (m/v) in PBS. For the 
hybrid hydrogels, the prepolymer solutions contained 7.5% (m/v) of Phe-PEA or Ala-PEA and 
2.5% (m/v) of PEG-DMA or MCS. The photoinitiator, 2-hydroxy-4’-(2-hydroxyethoxy)-2-
methylpropiophenone (Irgacure 2959, Sigma-Aldrich) was added last to the solution at a 
concentration of 0.15% (m/v). The prepolymer solution was then transferred to a 1 mL syringe 
(Thermo Scientific, Waltham, MA, USA), and photo-crosslinked with long-wavelength 
ultraviolet light (365 nm) at an intensity of 16 mW/cm2 for 4 min (2 min on each side of the 
syringe).  
 
Measurement of gel content and equilibrium water content. Gel content and equilibrium 
water content (EWC) were measured in cell-free hydrogels (n = 3). After photo-crosslinking, the 
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initial mass (mi) of each hydrogel was recorded and the theoretical mass (mt) of polymers 
involved in crosslinking was calculated as mi x 0.1 based on 10 m/v % in the formulation. The 
hydrogels were then swollen in PBS for 24 hr, and the swollen mass (ms) was recorded to 
determine the EWC. Then, the hydrogels were rinsed three times successively in distilled water 
for 3 hr to remove remaining non-crosslinked materials and salts from PBS. Following the rinses, 
the hydrogels were frozen in liquid N2, lyophilized, and their dry masses (md) were measured. 
The gel content and EWC were calculated using equations (1) and (2) respectively:  
Gel	content = 	!!
!"
	x	100%                              (1) 
EWC = 	!#"	!!
!#
	x	100%                               (2) 
 
Measurement of mass swelling ratio. After the hydrogels were prepared, their masses (mi) were 
recorded. The hydrogels were then swollen to equilibrium in PBS at 37 °C for 24 hr, and the 
swollen mass was recorded (ms). The mass swelling ratio was calculated according to the 
following equation:  
Mass	swelling	ratio = 	!#"	!$
!$
	x	100%           (3) 
 
Measurement of the Young’s moduli under unconfined compression. Cylindrical samples 
with diameters of ~5 mm and heights of ~10 mm (n = 3) were prepared in 1 mL syringes as 
described above and equilibrated in PBS for 24 hr. Before compression testing, the dimensions of 
the swollen hydrogels were accurately measured using calipers. Unconfined stress-strain 
measurements were conducted using a UniVert system (CellScale, Waterloo, ON, Canada), 
equipped with a 0.5 N load cell. During the measurement, the samples were immersed in a 37 °C 
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PBS bath, preloaded at 0.01 N at every cycle, and compressed to a total strain of 20% at a rate of 
0.6%/s. The nominal stress was calculated by dividing the applied force by the initial cross-
sectional area of the sample. The compressive modulus was determined from the slope of the 
linear region of the stress-strain curve between 10 and 15% strain.  
 
Human adipose-derived stromal cell isolation and culture. Adipose tissue was obtained with 
informed consent from female patients undergoing elective lipo-reduction surgeries at the 
University Hospital and St. Joseph’s Hospital in London, ON, Canada, with Human Research 
Ethics Board approval from Western University (Protocol #105426). Within 2 hr of extraction, 
the samples were transported to the lab on ice in sterile phosphate buffer saline (PBS) 
supplemented with 20 mg/mL bovine serum albumin (BSA). Human ASCs were isolated within 
2 hr of procurement using previously published methods [51, 52]. The cells were cultured in 
proliferation medium comprised of DMEM:Ham’s F-12 medium (Wisent Bio Products, 
Montreal, QC) supplemented with 10% fetal bovine serum (FBS; Wisent Bio Products) and 100 
U/mL penicillin and 0.1 mg/mL streptomycin (1% pen-strep; Wisent Bio Products). Fresh 
proliferation medium was provided every 2-3 days. The cells were passaged at 80% confluence 
using 0.25% trypsin/0.1% EDTA (Wisent Bio Products) and re-plated in new flasks at 6,000-
7,000 cells/cm2. Passage 4 (P4) ASCs were used for all cell encapsulation studies, and each study 
was repeated with three different donors (N = 3).  
  
ASC encapsulation and culture within Phe-PEA/Ala-PEA based hydrogels. The polymer 
solutions of Phe-PEA or Ala-PEA were prepared as described for the fabrication of the 
hydrogels. ASCs at P4 were suspended in proliferation medium at a concentration of 1 x 107 
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cells/mL and combined with the polymer solution for hydrogel encapsulation. The final solution 
volume contained 80% polymer solution and 20% ASC suspension by volume and was then 
photo-crosslinked as described above. Immediately after crosslinking, the hydrogels were cut into 
25 µL volume disks, each containing ~2.5 x 105 cells, transferred into 12-well inserts (Greiner 
Bio-one, Germany), and cultured in proliferation medium at 37 °C with 5% CO2. After 24 hr, the 
hydrogels were transferred into serum-free adipogenic differentiation medium comprised of 
DMEM:Ham’s F-12 nutrient mixture supplemented with 1% pen-strep, 33 µM biotin, 17 µM 
pantothenate, 10 µg/mL transferrin, 100 nM hydrocortisone, 66 nM insulin, and 1 nM 
triiodothyronine, with 0.25 mM isobutylmethylxanthine and 1 µg/mL troglitazone included for 
the first 72 hr [53]. Fresh medium was provided to all samples every 2-3 days.   
   
Cell viability. Viability of the encapsulated ASCs in the Phe-PEA and Ala-PEA hydrogels was 
assessed at 24 hr after encapsulation and at 7 days after the induction of adipogenic 
differentiation (n = 3 replicate scaffolds/trial, N = 3 trials with different ASC donors) using the 
LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells (Cat. # L-3224; Life Technologies 
Inc., Burlington, ON, Canada). During preparation, the hydrogels were rinsed twice in PBS 
before incubation in 1X staining solution for 45 min at 37 °C. Next, the hydrogels were rinsed 
two times with PBS before imaging using a Zeiss LSM 800 confocal microscope (Zeiss Canada, 
Toronto, ON, Canada). The complete cross-sectional area of each hydrogel was imaged at 10X 
magnification and mosaic images were generated using the Zen software (Zeiss Canada) stitching 
command.  A total of 5 layers, separated by 75 µm, were imaged for each hydrogel sample. 
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Image J analysis software was used to quantify the number of live and dead cells in each layer in 
order to calculate the average cell viability and density for each group.  
 
Glycerol-3-phosphate dehydrogenase (GPDH) activity. Quantitative assessment of ASC 
adipogenesis was conducted by measuring intracellular GPDH enzyme activity in the Phe-PEA 
and Ala-PEA hydrogels at 7 days after adipogenic induction (n = 3, N = 3) using a GPDH 
Enzyme Activity Measurement Kit (Kamiya Biomedical Corporation, Cat. # KT-010, Seattle, 
WA, USA) following published methods [54, 55]. ASCs cultured on tissue culture polystyrene in 
6-well plates in proliferation medium (non-induced) or adipogenic differentiation medium 
(induced) for 7 days were included as assay controls. To normalize the GPDH activity levels, the 
total cytosolic protein content for all samples was measured using the Pierce 660 Protein Assay 
Kit (Thermo Scientific, Waltham, MA, USA) with an albumin standard. Total protein content 
and GPDH activity were measured using a CLARIOstar® spectrophotometer (BMG Labtech, 
Ortenberg, Germany).  
  
BODIPY staining. Qualitative assessment of ASC adipogenesis was performed using BODIPY® 
493/503 staining (Thermo Scientific, Waltham, MA, USA) to visualize intracellular lipid 
accumulation in the ASCs encapsulated in the Phe-PEA and Ala-PEA hydrogels at 7 days after 
adipogenic induction (n = 3, N = 3). The BODIPY® was reconstituted in DMSO at 1 mg/mL and 
diluted in PBS by a factor of 1:500. The hydrogels were rinsed two times in PBS and then 
incubated in the staining solution at 37 °C for 1 hr. Following incubation, the hydrogels were 





Statistical analysis. Data are reported as the mean ± standard deviation (SD), and the statistical 
analyses were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA) by 
two-way ANOVA with a Tukey’s post-hoc test (Figures 3, 5) or t-test (Figure 4g, 6). Differences 
were considered statistically significant at p < 0.05.  
 
Results and Discussion 
Polymer synthesis and characterization. The initial objective was to synthesize water-soluble 
PEAs containing crosslinkable moieties in their backbones to allow for hydrogel formation in 
aqueous conditions for ASC encapsulation. Monomers 1a, 1b, and 1c (Scheme 1) were 
synthesized as previously reported from L-phenylalanine or L-alanine and 1,4-butanediol or 1,8-
butanediol via Fischer esterification [48, 49]. The aim was to compare the effects of the different 
amino acids and diols on the properties of the resulting PEA hydrogels. However, the monomer 
composed of L-alanine and 1,4-butanediol could not be prepared in acceptable yield and purity 
for polymerization. Diamino PEG macromonomer (2) (2000 g/mol) was prepared as described in 
the supporting information via tosylation and subsequent amination of PEG diol. The role of 
macromonomer 2 was to impart water-solubility to the resulting PEAs. Di-p-nitrophenyl 
fumarate (3) was synthesized as previously reported [48] to provide crosslinkable moieties along 





Scheme 1. PEA synthesis from different monomer combinations. 
 
 The monomers were polymerized under solution polycondensation conditions in DMA at 
70 ºC using NEt3 as a base to deprotonate the ammonium salts 1a-c (Scheme 1). Unlike previous 
PEA syntheses under similar conditions [49], it was necessary to reduce the polymerization time 
from 48 hr to 6 hr to avoid undesired crosslinking of the resulting PEAs, which resulted in 
insoluble gels, presumably due to crosslinking reactions of backbone alkenes from the 
fumaramide units by Michael-type additions of remaining diamine monomers such as 1 or 2 or 
due to radical generation upon prolonged heating. Three different ratios of monomers 1:2 were 
examined: 50:50, 40:60 and 30:70. While higher ratios of 1:2 led to water-insoluble PEAs, at 
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30:70 monomers 1:2 both Phe-PEA and Ala-PEA were soluble. However, Phe-8-PEA was not 
water-soluble for any of the prepared ratios. 
 The molar masses of the polymers were determined by SEC (Table 1). All of the PEAs had 
Mn values close to 20 kg/mol and Đ values ranging from 2.5 – 3.0. The absence of unreacted 
macromonomer 2 was confirmed by the absence of a peak in the SEC trace at the location 
expected for 2000 g/mol PEG (Figure S9). The Đ values were higher than expected for a step-
growth polymerization, where they should approach 2.0. This result can likely be attributed to a 
small degree of crosslinking, which was not a concern as the PEAs were designed to be 
incorporated in subsequent steps into a network.  
 
Table 1. Molar mass data for the PEAs, as measured by SEC.   
Polymer Mn (kg/mol) Mw (kg/mol) Đ 
Phe-PEA 19.9 49.2 2.46 
Phe-8-PEA 20.1 56.6 2.81 
Ala-PEA 18.9 56.1 2.96 
 
 1H NMR and FT-IR spectroscopic analyses were consistent with the structures of the 
proposed polymers. 1H NMR spectra had peaks at ~8.8 and 8.5 ppm corresponding to the amide -
NH- protons adjacent to monomers 1 and macromonomer 2 respectively (Figure 1, S5-S7). The 
spectra also had peaks at ~6.8 ppm corresponding to the =CH fumaramide units along the 
backbone and peaks at 3.5 ppm corresponding to PEG. The spectrum of Phe-PEA was 
differentiated from that of Ala-PEA by the presence of peaks corresponding to the pendent 
phenyl groups of phenylalanine from 7.3 to 7.2 ppm, and the peaks from 3.1 – 2.9 ppm due to the 
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-CH2- moieties adjacent to the phenyl groups (Figure 1a). In contrast, Ala-PEA had peaks at ~1.3 
ppm corresponding to the backbone octyl chain and pendent methyl groups on alanine (Figure 
1b). Overall, the integrations of the peaks corresponded closely to the feed molar ratios of 
monomer 1:2:3 at 0.3:0.7:1.0 (Figures S5-S7). The FT-IR spectra were also consistent with the 
successful synthesis of PEAs with characteristic peaks corresponding to the amide N-H stretch at 
3300 cm-1, the ester C=O stretch at 1740 cm-1, the amide C=O stretch at 1640 cm-1, and the amide 
N-H bend at 1550 cm-1 (Figure S8).  
  
Figure 1. 1H NMR spectra of a) Phe-PEA and b) Ala-PEA in DMSO-d6 (400 MHz).  
 
Fabrication and characterization of hydrogels. After the successful synthesis of the water-
soluble PEAs Phe-PEA and Ala-PEA with backbone alkenes for crosslinking, their gelation was 
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investigated. Irgacure 2959 was used as a photoinitiator at a concentration of 0.15% (m/v). In 
addition to formulations incorporating only the PEAs (10 % m/v) and initiator, formulations 
incorporating PEG-DMA or MCS at 2.5% (m/v) (Figure 2) in addition to PEA at 7.5% (w/v) 
were also investigated to tune the hydrogel properties. PEG-DMA was selected because PEG 
tends to be well tolerated in vivo and has been extensively used for hydrogel formation [10, 56]. 
MCS was selected as it has previously been shown to provide a microenvironment that supports 
the viability and adipogenic differentiation of encapsulated human ASCs [54, 55], and increased 
production of soluble and cell-associated chondroitin 4-sulphate proteoglycans has also been 
linked to adipogenesis in the murine 3T3-L1 preadipocyte cell line [57]. Crosslinking was 
performed in syringes and was induced by irradiation with 365 nm light for 4 min (2 min per side 
of syringe). These conditions were previously found to be well tolerated by ASCs when 
encapsulated into MCS-based hydrogels [58]. 
  
Figure 2. Chemical structures of a) PEG-DMA and b) MCS.  
 
 To understand the effects of the different hydrogel compositions on their properties, all of 
the hydrogels were characterized by the measurement of their gel content, EWC and mass 
swelling ratio.  Gel content is the mass percentage of material successfully incorporated into the 
network, while EWC represents the swelling degree of the crosslinked network with water 
relative to the dry weight of gel. For gel content, there was a common trend that all Phe-PEA-
based systems had a higher gel content than the Ala-PEA-based systems (Figure 3a). However, 
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the difference was only statistically significant for the systems with PEG-DMA incorporated. The 
incorporation of PEG-DMA or MCS generally decreased the gel content relative to that of the 
pure PEA, but again the difference was only statistically significant when comparing pure Ala-
PEA to Ala-PEA + PEG-DMA. The results suggest that the additives disrupted the crosslinking 
to a small extent, perhaps due to phase separation with the PEA or due to poor compatibility of 
the methacrylates with the fumaramides in the polymerization reaction. There were no significant 
differences in the EWC across the examined hydrogels. Although the differences were not 
statistically significant, the Ala-PEA hydrogels tended to swell more than the Phe-PEA 
hydrogels. Higher swelling may be attributed to the trend towards lower gel content for the Ala-
PEA hydrogels, as lower gel content would suggest a lower density of crosslinks in the network. 
However, it could also relate to the relative hydrophilicities of the PEAs. Although the alanine-
based monomer 1c has a longer aliphatic diol chain than the phenylalanine monomer 1a, the 
methyl side chains on alanine are much less hydrophobic than the phenyl side chains of 
phenylalanine. Overall, the hydrogels with PEG-DMA and MCS incorporated tended to swell 
more than those prepared from pure PEAs. This result may relate to their lower gel content, and 





Figure 3. a) Gel content of the hydrogels; b) Equilibrium water content of the hydrogels; c) Mass 
swelling ratio of the hydrogels. The experiments were performed in triplicate and the data are 
presented as the mean, with error bars corresponding to the SD. Data were analyzed by two-way 
ANOVA with a Tukey’s post-hoc comparison of the means (p < 0.05). *denotes a statistically 
significant difference between groups. 
  
 The Young’s moduli of selected hydrogels were evaluated under unconfined compression. 
These efforts focused on hydrogels composed of the pure PEAs as hybrid hydrogels containing 
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PEG-DMA or MCS were very brittle and tended to fracture (Figure 4a-f), making compression 
testing impossible and prohibiting their inclusion in the cell encapsulation studies. Similar to their 
lower gel contents, the poor mechanical properties of the hydrogels containing PEG-DMA or 
MCS can likely be attributed to the disruption of crosslinking due to polymer phase separation or 
incompatibilities between crosslinking moieties.  
  
Figure 4. Representative images of the hydrogels after removal from the syringe mold: a) Phe-
PEA, b) Phe-PEA + PEG-DMA, c) Phe-PEA + MCS, d) Ala-PEA, e) Ala-PEA + PEG-DMA and 
f) Ala-PEA + MCS. Scale bar: 5 mm. Hydrogels prepared with PEG-DMA and MCS tended to 
fracture. g) Comparison of the Young’s moduli of Phe-PEA and Ala-PEA measured under 
unconfined compression.  The experiments were performed in triplicate and the data are 
presented as the mean, with error bars corresponding to the SD. Data were analyzed by a t-test (p 
< 0.05). *denotes a statistically significant difference between groups.  
 
 For the pure PEAs, Phe-PEA had a modulus of 106 ± 11 kPa and Ala-PEA had a modulus 
of 44 ± 13 kPa. The higher moduli for the Phe-PEA hydrogels may result from their trend 
towards lower EWC and swelling relative to the Ala-PEA systems, as this would result in a 
higher density of polymer in the network, leading to higher stiffness. Hydrophobic interactions 
between the phenyl groups in Phe-PEA, may also contribute to higher stiffness. The moduli of 
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both hydrogels were higher than that of adipose tissue, which is ~ 2-4 kPa, but in the range of 
other soft tissues such as muscle, bladder, and cornea [59] and similar to previous chitosan- and 
chondroitin sulfate-based hydrogels that have been shown to support the viability and adipogenic 
differentiation of ASCs [54]. 
 
Cell viability. To assess the capacity of the hydrogel scaffolds to support ASCs during 
encapsulation and adipogenic induction, the viability of ASCs encapsulated in the Phe-PEA and 
Ala-PEA hydrogels was assessed at 24 hr post-encapsulation, as well as at 7 days after 
adipogenic induction, through LIVE/DEAD® imaging analysis by confocal microscopy (Figure 
5). Visualization of the cell distribution across the complete cross-section of the hydrogels 
revealed that there was a more homogenous distribution of ASCs in the Ala-PEA hydrogels, 
which was particularly evident at 24 hr (Figure 5a). Notably, the Phe-PEA polymer solution was 
more viscous, which made mixing to combine it with the ASC suspension more challenging and 






Figure 5. Viability analysis of ASCs encapsulated in the Phe-PEA and Ala-PEA hydrogels. 
Representative images of the encapsulated ASCs at a) 24 hr after encapsulation and b) 7 days 
after adipogenic induction displaying the distribution of live (green; calcein-AM+) and dead (red; 
ethidium homodimer-1+) cells. Higher magnification images of the boxed regions in each 
complete hydrogel cross-section (scale bar: 500 µm) are shown on the right (scale bar: 50 µm). 
c) Percent viability and d) average number of viable ASCs per xy plane in the Phe-PEA and Ala-
PEA hydrogels. Data are presented as the mean with error bars corresponding to the standard 
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deviations (n = 3 hydrogel replicates/trial, N = 3 trials with different ASC donors). Data were 
analyzed by two-way ANOVA with a Tukey’s post-hoc comparison of the means. No significant 
differences were observed between any of the groups.  
 
 Quantification of the staining at 24 hr post-encapsulation indicated that the ASC viability in 
both the Phe-PEA and Ala-PEA hydrogels was > 75%, with no significant differences observed 
between the systems (Figure 5c). These findings are similar to previous levels observed with 
human ASCs encapsulated into MCS or methacrylated glycol chitosan (MGC) hydrogels via 
light-initiated crosslinking [54]. Overall, the viability results at 24 hr support that the 
encapsulation process was well-tolerated by the human ASCs. While not statistically significant, 
lower ASC viability was observed after 7 days of culture in adipogenic differentiation medium 
for both hydrogel groups. Again, these results are consistent with previous levels reported for the 
ASCs encapsulated in the MCS and MGC hydrogels, where a decline in viability was observed 
after 14 days of culture in adipogenic differentiation medium [54]. While favorable for inducing 
growth arrest in order to stimulate ASC adipogenesis, the lack of serum within the adipogenic 
differentiation medium may have contributed to the trend for declining viability over time in 
culture. To try to mitigate these effects, in the future it would be interesting to explore the 
incorporation of ECM components, such as decellularized adipose tissue (DAT) particles, which 
were previously shown to enhance the long-term viability and adipogenic differentiation of ASCs 
within the MCS and MGC hydrogels [54].  Similar to the viability results, there were no 
significant differences observed in the viable cell density per plane for either of the hydrogel 
groups at both time points studied  (Figure 5d), indicating that differences in ASC density were 
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not a confounding factor in comparing the levels of adipogenic differentiation between the two 
systems [55]. 
 
Assessment of adipogenesis. The capacity of the hydrogels to support the adipogenic 
differentiation of the encapsulated ASCs for potential adipose tissue engineering applications was 
also assessed. Quantification of GPDH enzyme activity, which is upregulated during ASC 
adipogenesis, indicated that there were no significant differences between the Phe-PEA and Ala-
PEA groups at 7 days post-induction of differentiation, with both groups showing enhanced 
levels compared to the non-induced tissue culture controls (Figure 6a). The GPDH activity levels 
observed were similar to those previously reported for the human ASCs encapsulated in the MCS 
and MGC hydrogels at 7 days [54]. The enhanced GPDH activity in the induced tissue culture 
controls relative to the hydrogel groups may be related to the high levels of cell-cell contact 
achieved in the high-density 2-D cultures as compared to the distribution of single cells that was 
observed within the hydrogels [55, 60]. Consistent with the GPDH results, BODIPY staining 
revealed a qualitatively-similar and abundant number of lipid-loaded cells in both the Phe-PEA 
and Ala-PEA hydrogels (Figure 6b), confirming that both systems were supportive of ASC 
adipogenesis. In the future, it would be worthwhile to explore the effects of increasing the cell 
density within the hydrogels, as well as extending the studies to longer timepoints, to elucidate 
whether there may be subtle differences in the capacity of the two PEA formulations to promote 







Figure 6. In vitro analysis of ASC adipogenesis within the hydrogels at 7 days post-induction of 
differentiation. a) GPDH enzyme activity for ASCs encapsulated in either Phe-PEA or Ala-PEA 
hydrogels. Data are presented as the mean with error bars corresponding to the standard 
deviations (n = 3 hydrogel replicates/trial, N = 3 trials with different ASC donors). Dotted and 
dashed lines represent the mean values for the induced (cultured in adipogenic differentiation 
medium) and non-induced (cultured in proliferation medium) tissue culture control groups 
respectively. The hydrogel groups were compared with a t-test and no significant differences 
were observed. b) Representative images of BODIPY-stained (green) ASCs encapsulated in the 
Phe-PEA and Ala-PEA hydrogels showing qualitatively similar numbers of differentiating ASCs 
containing intracellular lipid droplets after 7 days of culture in adipogenic differentiation 





New water-soluble PEAs with crosslinkable moieties in their backbones were successfully 
synthesized from a phenylalanine-based monomer, alanine-based monomer, p-nitrophenyl 
fumarate and a PEG diamine. The PEAs were only water soluble when a 70:30 ratio of 
PEG:amino acid monomer was used and for Phe-PEA and Ala-PEA, but not Phe-8-PEA. Using 
365 nm light and a photoinitiator, hydrogels were prepared from the pure PEAs (10% w/v) and 
from the PEAs (7.5% w/v) with either PEG-DMA (2.5% w/v) or MCS (2.5% w/v). The Phe-PEA 
hydrogels tended to exhibit higher gel content, lower EWC and less swelling than the Ala-PEA 
hydrogels, though the differences were small and not statistically significant in many cases. The 
incorporation of PEG-DMA or MCS tended to decrease the gel content, increase the EWC, 
increase the swelling, and made the hydrogels brittle. Hydrogels composed of pure Phe-PEA and 
Ala-PEA had Young’s moduli of 106 and 44 kPa respectively. Human ASCs were successfully 
encapsulated within the Phe-PEA and Ala-PEA hydrogels via light-initiated crosslinking, with 
viabilities higher than 75% at 24 hr. While there was a trend towards declining viability over time 
in culture, the Phe-PEA and Ala-PEA hydrogels were shown to similarly support the adipogenic 
differentiation of the encapsulated ASCs, with an abundant number of lipid-loaded cells observed 
after only 7 days of culture in adipogenic differentiation medium. Overall, the findings support 
the further investigation of these novel water-soluble PEAs as an ASC delivery platform for 
applications in adipose tissue regeneration.     
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